Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析

◆英語タイトル:Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME648FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Bio-Rad Laboratories Inc (BIO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for the life science research, healthcare, analytical chemistry and other markets. The company’s major products include reagents, apparatus, laboratory instruments, test systems, informatics systems, test kits and specialized quality controls. Bio-Rad offers its products to universities and medical schools, industrial research organizations, pharmaceutical manufacturers, government agencies, biotechnology researchers, food producers, food testing laboratories, reference laboratories, hospital and transfusion laboratories, and physician office laboratories. It markets products through direct sales force and also through a network of distributors, agents, brokers and resellers across the world. The company operates in the US, Canada, Latin America, Europe and Asia, among others. Bio-Rad is headquartered in Hercules, California, the US.

Bio-Rad Laboratories Inc Key Recent Developments

Mar 06,2021: Bio-Rad to Participate in Barclays Global Healthcare Conference 2021
Feb 11,2021: Bio-Rad Reports Fourth-Quarter and Full-Year 2020 Financial Results
Dec 10,2020: Bio-Rad provides outlook through 2023
Oct 29,2020: Bio-Rad reports third-quarter 2020 financial results
Sep 14,2020: Bio-Rad introduces StarBright Violet 515 Dye for Flow Cytometry

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Bio-Rad Laboratories Inc – Key Facts
Bio-Rad Laboratories Inc – Key Employees
Bio-Rad Laboratories Inc – Key Employee Biographies
Bio-Rad Laboratories Inc – Major Products and Services
Bio-Rad Laboratories Inc – History
Bio-Rad Laboratories Inc – Company Statement
Bio-Rad Laboratories Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Bio-Rad Laboratories Inc – Business Description
Business Segment: Clinical Diagnostics
Overview
Performance
Key Stats
Business Segment: Life Science
Overview
Performance
Key Stats
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other
Target Markets
Performance
Geographical Segment: United States
Performance
R&D Overview
Bio-Rad Laboratories Inc – Corporate Strategy
Bio-Rad Laboratories Inc – SWOT Analysis
SWOT Analysis – Overview
Bio-Rad Laboratories Inc – Strengths
Bio-Rad Laboratories Inc – Weaknesses
Bio-Rad Laboratories Inc – Opportunities
Bio-Rad Laboratories Inc – Threats
Bio-Rad Laboratories Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Bio-Rad Laboratories Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 06, 2021: Bio-Rad to Participate in Barclays Global Healthcare Conference 2021
Feb 11, 2021: Bio-Rad Reports Fourth-Quarter and Full-Year 2020 Financial Results
Dec 10, 2020: Bio-Rad provides outlook through 2023
Oct 29, 2020: Bio-Rad reports third-quarter 2020 financial results
Sep 14, 2020: Bio-Rad introduces StarBright Violet 515 Dye for Flow Cytometry
Aug 04, 2020: The United States Court of appeals for the Federal Circuit affirms that 10x genomics willfully infringed Bio-Rad U.S. patent and upholds lower court’s award of damages
Jul 30, 2020: Bio-Rad reports second-quarter 2020 financial results
May 06, 2020: Bio-Rad reports first-quarter 2020 financial results
Mar 02, 2020: BIO-RAD LABORATORIES: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.
Feb 13, 2020: Bio-Rad reports fourth-quarter and full-year 2019 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Bio-Rad Laboratories Inc, Key Facts
Bio-Rad Laboratories Inc, Key Employees
Bio-Rad Laboratories Inc, Key Employee Biographies
Bio-Rad Laboratories Inc, Major Products and Services
Bio-Rad Laboratories Inc, History
Bio-Rad Laboratories Inc, Subsidiaries
Bio-Rad Laboratories Inc, Key Competitors
Bio-Rad Laboratories Inc, Ratios based on current share price
Bio-Rad Laboratories Inc, Annual Ratios
Bio-Rad Laboratories Inc, Annual Ratios (Cont...1)
Bio-Rad Laboratories Inc, Annual Ratios (Cont...2)
Bio-Rad Laboratories Inc, Interim Ratios
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Bio-Rad Laboratories Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ARYZTA AG:企業の戦略・SWOT・財務情報
    ARYZTA AG - Strategy, SWOT and Corporate Finance Report Summary ARYZTA AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • The British United Provident Association Ltd-製薬・医療分野:企業M&A・提携分析
    Summary The British United Provident Association Ltd (Bupa) is a leading global healthcare group. It offers health insurance and other funding products, chronic disease management services, home healthcare services, workplace health services and care services, comprising residential and nursing home …
  • The US Oncology Network:企業の戦略的SWOT分析
    The US Oncology Network - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Coloplast A/S:戦略・SWOT・企業財務分析
    Coloplast A/S - Strategy, SWOT and Corporate Finance Report Summary Coloplast A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Wegmans Food Markets Inc:企業の戦略的SWOT分析
    Wegmans Food Markets Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Titan Machinery Inc. (TITN):企業の財務・戦略的SWOT分析
    Titan Machinery Inc. (TITN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • NEC Corp (6701):企業の財務・戦略的SWOT分析
    NEC Corp (6701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Vaccinex Inc (VCNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that discovers and develops targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company’s lead platform technologies include antibody platform and ActivMAb, SEMA4D, and antibody d …
  • Kayson Inc:企業の戦略・SWOT・財務分析
    Kayson Inc - Strategy, SWOT and Corporate Finance Report Summary Kayson Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Voyager Therapeutics Inc (VYGR):製薬・医療:M&Aディール及び事業提携情報
    Summary Voyager Therapeutics Inc (Voyager) is a clinical-stage gene therapy company that develops treatments for patients suffering from severe neurological diseases. The company provides treatment for adeno-associated virus gene therapy field by selecting, designing and manufacturing vectors. Its c …
  • Circle K Stores Inc:企業の戦略・SWOT・財務情報
    Circle K Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Circle K Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Internet Initiative Japan Inc (3774):企業の財務・戦略的SWOT分析
    Internet Initiative Japan Inc (3774) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Fresenius Medical Care AG & Co KGaA (FMS)-医療機器分野:企業M&A・提携分析
    Summary Fresenius Medical Care AG & Co KGaA (Fresenius Medical), a subsidiary of Fresenius SE & Co KGaA, is an integrated dialysis company. It is one of the largest kidney dialysis companies in the world. It provides dialysis care services and products to individuals with chronic kidney failure. It …
  • LG International Corp (001120):企業の財務・戦略的SWOT分析
    LG International Corp (001120) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Infant Bacterial Therapeutics AB (IBT B):企業の財務・戦略的SWOT分析
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops drugs influencing the human infant microbiome to treat rare diseases in premature infants. Its pipeline product candidates include IBP-9414, containing the active substance Lactobacil …
  • Carnival Corporation & plc:企業の戦略・SWOT・財務情報
    Carnival Corporation & plc - Strategy, SWOT and Corporate Finance Report Summary Carnival Corporation & plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • U.S. Energy Corp (USEG):企業の財務・戦略的SWOT分析
    Summary U.S. Energy Corp (US Energy) is an oil and gas company that offers exploration, development and production of oil and natural gas properties. The company provides maintenance of mineral properties. It operates its oil and gas prospects located in the Williston Basin of North Dakota, the Eagl …
  • Iridex Corp (IRIX)-医療機器分野:企業M&A・提携分析
    Summary Iridex Corp (IRIDEX) is a medical device company that manufactures and distributes laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. The company provides products such as lasers, laser delivery devices, glaucoma devi …
  • Australian Broadcasting Corporation:企業の戦略的SWOT分析
    Australian Broadcasting Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Sunesis Pharmaceuticals Inc (SNSS):企業の財務・戦略的SWOT分析
    Sunesis Pharmaceuticals Inc (SNSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆